Staska Pharmaceuticals, Inc.: Drug Recall
Recall #D-0040-2025 · 09/30/2024
Class I: Dangerous
Recall Details
- Recall Number
- D-0040-2025
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Staska Pharmaceuticals, Inc.
- Status
- Terminated
- Date Initiated
- 09/30/2024
- Location
- Bennet, NE, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4773 vials
Reason for Recall
Presence of Particulate Matter: Presence of glass particulates.
Product Description
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Distribution Pattern
Nationwide in the USA
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.